VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.
Also called NCT04655742
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT04655742
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04655742. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06-27 (actual); primary completion 2017-09-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- VitaFlow™ Transcatheter Aortic Valve System
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Record details
- Record id
cardio:ct-nct04655742- Content hash
236a8bca59d3ca4a891f6694c912f79c2b0304bd23288f7c51149144260e05d1